Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Market Size (2025) | USD 2.80 Billion |
| Market Size (2030) | USD 3.61 Billion |
| Growth Rate (2025 - 2030) | 5.22% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Bariatric Surgery Market Analysis by Mordor Intelligence
The bariatric surgery market generated USD 2.80 billion in 2025 and is on track to reach USD 3.61 billion by 2030, expanding at a 5.22% CAGR; this market size outlook reflects sustained demand for definitive weight-loss procedures amid pharmaceutical competition and growing payer support. Recent procedure data show sleeve gastrectomy retaining majority preference, while intragastric balloons and endoscopic sleeve gastroplasty gain momentum. Provider investments in robotic systems, artificial-intelligence-enabled stapling tools, and digital follow-up platforms continue to lower complication risk and shorten recovery time. Rising obesity prevalence, broader employer coverage, and cost-effectiveness studies comparing surgery with long-term GLP-1 therapy strengthen the value proposition for health systems. Simultaneously, the shift toward ambulatory surgical centers (ASCs) indicates that outpatient models are reshaping the bariatric surgery market as payers incentivize same-day procedures.
Key Report Takeaways
- By procedure type, sleeve gastrectomy led with 57.13% bariatric surgery market share in 2024, Intragastric balloons are forecast to expand at a 5.45% CAGR through 2030.
- By device type, assisting devices accounted for 64.53% of the bariatric surgery market size in 2024, Implantable devices are projected to grow at 6.12% CAGR between 2025-2030.
- By end user, hospitals and specialty clinics held 71.23% share of the bariatric surgery market size in 2024, Ambulatory surgical centers are advancing at a 5.96% CAGR through 2030.
- By patient age, adults 18-64 controlled 83.12% share in 2024; adolescent procedures are rising at a 5.78% CAGR.
Global Bariatric Surgery Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Escalating global obesity prevalence | +1.8% | Global, with highest impact in North America & Asia-Pacific | Long term (≥ 4 years) |
| Preference for minimally-invasive & day-care procedures | +1.2% | North America & Europe, expanding to Asia-Pacific | Medium term (2-4 years) |
| Growing reimbursement for metabolic surgery | +0.9% | North America & Europe primarily | Medium term (2-4 years) |
| Rapid uptake of robotic & endoscopic bariatric technologies | +0.7% | Global, led by developed markets | Short term (≤ 2 years) |
| Bariatric surgery shown more cost-effective than GLP-1 drugs | +0.6% | Global, particularly in markets with high pharmaceutical costs | Long term (≥ 4 years) |
| Employer-sponsored bariatric coverage & wellness incentives | +0.4% | North America primarily, emerging in Europe | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Escalating Global Obesity Prevalence
WHO projects 1.53 billion individuals living with obesity by 2035, up from 1 billion in 2022, intensifying demand for surgical solutions that provide durable weight loss[1]Source: WHO, “Obesity and Overweight,” who.int . Emerging economies exhibit the steepest prevalence climb as urban diets replace traditional nutrition. Health-care systems face surging costs tied to diabetes and cardiovascular comorbidities, estimated at USD 147 billion annually in the United States, prompting public and private payers to endorse bariatric procedures as cost-saving over a lifetime. Regulators have responded with faster device approval pathways that support innovation while maintaining safety. These developments collectively bolster bariatric surgery market growth across all income settings.
Preference for Minimally Invasive & Day-Care Procedures
Outpatient bariatric cases grew 13% across U.S. ASCs between 2023-2025, reflecting patient demand for shorter stays and payer incentives for lower facility fees. Endoscopic sleeve gastroplasty and advanced balloon systems allow same-day discharge without abdominal incisions, reducing recovery time and postoperative pain. Robotic platforms approved in 2024 enable precise stapling and suturing that limit leakage risk. Medicare and major commercial insurers updated fee schedules to reimburse outpatient metabolic surgery, accelerating ASC adoption. Accreditation programs now include rigorous outpatient quality standards, assuring stakeholders of postoperative safety comparable with inpatient care.
Growing Reimbursement for Metabolic Surgery
The U.S. Centers for Medicare & Medicaid Services extended national coverage to metabolic procedures that improve hypertension and sleep apnea, expanding the eligible patient pool. Large employers introduced bariatric bundles with full coverage after evidence showed surgical interventions recoup costs within three years through comorbidity savings. In Europe, single-payer systems added adolescent surgery reimbursement following pediatric guideline updates. Payer recognition of long-term cost advantages over chronic GLP-1 therapy reinforces positive volume trends for the bariatric surgery market.
Rapid Uptake of Robotic & Endoscopic Technologies
Cleveland Clinic performed the first magnetic-guided robotic sleeve gastrectomy in 2025, demonstrating reduced instrument collisions and improved ergonomics. FDA clearances for new multi-port and single-port systems widened hospital access and compressed learning curves through augmented-reality guidance. Device makers integrated machine-learning algorithms that optimize staple height based on real-time tissue feedback, cutting leak incidence. Collectively, these advances improve outcomes and attract patients formerly hesitant about open surgery, accelerating adoption.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timelin |
|---|---|---|---|
| High upfront procedure & device costs | -1.4% | Global, particularly in emerging markets | Short term (≤ 2 years) |
| Post-operative complications & long-term follow-up burden | -0.8% | Global, with higher impact in markets with limited healthcare infrastructure | Long term (≥ 4 years) |
| Rising adoption of GLP-1 weight-loss medications | -1.2% | North America & Europe primarily | Medium term (2-4 years) |
| Surgeon capacity & centre-of-excellence volume requirements | -0.6% | Global, acute in rural and underserved areas | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Rising Adoption of GLP-1 Weight-Loss Medications
Enhanced efficacy profiles for semaglutide and tirzepatide delayed surgical consideration for many class-I and class-II obesity patients. Hospitals reported a 25% decline in elective bariatric bookings among non-diabetics during 2024. Nevertheless, long-term adherence challenges, weight-plateau effects, and drug intolerance drive a secondary wave of surgical candidates seeking definitive results. Providers now position surgery as a complementary step when pharmacotherapy reaches diminishing returns, partially mitigating volume erosion.
Surgeon Capacity & Center-Volume Requirements
Over 80% of U.S. general surgery residents pursue fellowships, tightening the pipeline for bariatric specialists. Accreditation rules demand high annual volumes and multidisciplinary teams, limiting program expansion in smaller hospitals. Remote proctoring and virtual simulation aim to bridge training gaps, yet near-term surgeon shortages persist, restraining the bariatric surgery market in underserved regions.
Segment Analysis
By Procedure Type: Sleeve Gastrectomy Maintains Leadership as Endoscopic Options Accelerate
Sleeve gastrectomy held a 57.13% bariatric surgery market share in 2024, driven by its balance of efficacy, safety, and straightforward technique. Hospitals favor the procedure for first-line surgical therapy, citing reduced complication rates relative to Roux-en-Y gastric bypass. The bariatric surgery market size for sleeve gastrectomy is forecast to grow steadily, but its dominance faces incremental dilution as reversible, incision-free methods enter mainstream practice.
Intragastric balloons represent the fastest-expanding category at a 5.45% CAGR through 2030, appealing to patients wary of irreversible changes. Roux-en-Y remains the gold standard for severe metabolic disease yet encounters slower growth due to complexity and nutritional follow-up needs. One-anastomosis gastric bypass gains traction in Europe for simplified reconstruction. Endoscopic sleeve gastroplasty bridges pharmaceutical and surgical care, fitting ASC workflows and broadening candidate pools, reinforcing overall bariatric surgery market momentum.
Note: Segment shares of all individual segments available upon report purchase
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF
By Device Type: Assisting Instruments Dominate While Implantables Outpace Growth
Assisting devices, encompassing trocars, staplers, and energy platforms, accounted for 64.53% of the bariatric surgery market size in 2024, reflecting their necessity across procedures. Robotic-compatible staplers with smart compression sensors raise safety profiles and command premium pricing.
Implantable devices, including electrical stimulators and dynamic balloons, achieve 6.12% CAGR by leveraging digital telemetry that supports remote monitoring. Manufacturers bundle cloud-based analytics with hardware sales, unlocking service revenues. Continuous innovation in adaptive balloon inflation and glucose-responsive stimulation extends clinical indications, underlining why implantables lead category growth inside the broader bariatric surgery market.
By End User: ASC Expansion Signals Outpatient Shift
Hospitals and specialty clinics retained 71.23% share in 2024 due to infrastructure depth and ability to manage high-risk cases; however, ASC throughput is rising at 5.96% CAGR as payers favor lower facility costs. The bariatric surgery market share held by ASCs will widen as robotic and endoscopic platforms become more portable and single-use devices cut sterilization overhead.
Accredited bariatric centers integrate nutrition, psychology, and telehealth into bundled programs, supporting lifetime weight-maintenance targets. Employer contracts increasingly direct patients to these centers of excellence, reinforcing specialized facility growth. This dynamic reallocates volumes from general hospitals toward purpose-built environments, shaping future service delivery within the bariatric surgery market.
Note: Segment shares of all individual segments available upon report purchase
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF
By Patient Age Group: Pediatric Adoption Grows Under New Guidelines
Adults 18-64 constituted 83.12% of 2024 volumes, reflecting recognized clinical evidence and payer coverage. The bariatric surgery market size attributable to adolescents rises fastest at 5.78% CAGR through 2030 after the American Academy of Pediatrics endorsed surgery for severe pediatric obesity.
Early intervention prevents lifelong comorbidities, and insurers are beginning to authorize adolescent cases when multidisciplinary care plans are in place. Seniors ≥ 65 remain a smaller segment, yet advances in minimally invasive techniques and enhanced recovery pathways improve eligibility, broadening future demand and reinforcing diversified growth across the bariatric surgery market.
Geography Analysis
North America generated 39.23% of global revenue in 2024, anchored by mature reimbursement, concentrated surgical expertise, and a robust device manufacturing base. The region experiences headwinds from GLP-1 uptake, yet pending coverage expansion for interventional metabolic therapies could re-ignite procedure volumes. Strong capital spending on robotics sustains hospital competitiveness within the bariatric surgery market.
Asia-Pacific leads growth at a 6.23% CAGR to 2030 as urbanization escalates obesity rates and middle-class patients secure insurance coverage. China invests heavily in surgeon training and robotic adoption, while India’s medical-tourism hubs offer cost-advantaged packages with international accreditation. Collectively, these drivers position the region as the primary engine for incremental bariatric surgery market revenue through the forecast horizon.
Europe maintains steady demand under universal health systems that reimburse surgery for BMI ≥ 35 kg/m² with comorbidities. Regulatory harmonization across the EU eases device approvals and cross-border provider collaboration. Latin America leverages affordable pricing and proximity to North America to attract foreign patients, stimulating facility upgrades. Middle East and Africa markets remain nascent but benefit from government diversification programs that prioritize non-oil health-care investment, gradually integrating into the global bariatric surgery market.
Get Analysis on Important Geographic Markets
Download PDF
Competitive Landscape
The bariatric surgery market shows moderate concentration: the top five suppliers collectively control half of device revenue, giving the sector a market concentration score of 6. Medtronic, Johnson & Johnson (Ethicon), and Boston Scientific retain scale advantages through diversified portfolios spanning stapling platforms, energy devices, and nascent robotic systems. Intuitive Surgical and Medtronic race to broaden bariatric indications for their robots, competing on ergonomics and cost of ownership.
Strategic acquisitions accelerate ecosystem development. Boston Scientific purchased Apollo Endosurgery in 2024, adding endoscopic sleeve gastroplasty technology that complements its staple-line reinforcement products. Merit Medical acquired EndoGastric Solutions to integrate transoral[2]Source: Merit Medical, “Acquisition of EndoGastric Solutions Press Release,” merit.com fundoplication skills with dynamic balloon concepts. Emerging players Allurion and Fractyl Health engage in disruptive R&D—swallowable balloons and duodenal mucosal ablation—that reduce facility requirements and appeal to ASCs.
Pharmaceutical entrants indirectly influence competition by delaying initial surgical demand but later supplying rebound candidates dissatisfied with drug plateaus. Device firms partner with weight-management apps and remote monitoring platforms, embedding hardware into comprehensive obesity-care ecosystems and reinforcing the competitive positioning of the bariatric surgery market.
Bariatric Surgery Industry Leaders
-
Intuitive Surgical Inc.
-
Olympus Corporation
-
Medtronic
-
Johnson and Johnson
-
Boston Scientific Corporation
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- May 2025: Medtronic announcing plans to separate its Diabetes business into a standalone company, potentially impacting integrated metabolic care approaches that combine bariatric surgery with continuous glucose monitoring systems
- October 2024: Merit Medical acquired EndoGastric Solutions for USD 105 million, gaining access to the TIF (Transoral Incisionless Fundoplication) procedure and EsophyX device portfolio.
Global Bariatric Surgery Market Report Scope
Bariatric surgery or weight loss surgery is one of the major treatment procedures for treating obesity. It is generally the last option for patients who have failed to lose weight by several other means. During this procedure, the stomach size is reduced by removing some parts of the stomach or using a gastric band.
The bariatric surgery market is segmented by device and geography. By device, the market is segmented as assisting devices, implantable devices, and other devices. Assisting devices are sub-segmented into suturing devices, closure devices, stapling devices, trocars, and other assisting devices. Implantable devices are sub-segmented into gastric bands, electrical stimulation devices, gastric balloons, and gastric emptying. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
The report also covers the market sizes and forecasts for the bariatric surgery market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
By Procedure Type, Value
| Sleeve Gastrectomy |
| Roux-en-Y Gastric Bypass |
| Adjustable Gastric Banding |
| Biliopancreatic Diversion with Duodenal Switch |
| One Anastomosis Gastric Bypass |
| Endoscopic Sleeve Gastroplasty |
| Other Procedures |
By Device Type, Value
| Assisting Devices | Suturing Device |
| Closure Device | |
| Stapling Device | |
| Trocars | |
| Other Assisting Devices | |
| Implantable Devices | Gastric Bands |
| Electrical Stimulation Devices | |
| Gastric Balloons | |
| Gastric Emptying | |
| Other Devices |
By End User, Value
| Hospitals & Specialty Clinics |
| Bariatric Surgery Centers |
| Ambulatory Surgical Centers |
| Others |
By Patient Age Group, Value
| Adolescents (12–17) |
| Adults (18–64) |
| Geriatric (≥65) |
By Geography, Value
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa |
| By Procedure Type, Value | Sleeve Gastrectomy | |
| Roux-en-Y Gastric Bypass | ||
| Adjustable Gastric Banding | ||
| Biliopancreatic Diversion with Duodenal Switch | ||
| One Anastomosis Gastric Bypass | ||
| Endoscopic Sleeve Gastroplasty | ||
| Other Procedures | ||
| By Device Type, Value | Assisting Devices | Suturing Device |
| Closure Device | ||
| Stapling Device | ||
| Trocars | ||
| Other Assisting Devices | ||
| Implantable Devices | Gastric Bands | |
| Electrical Stimulation Devices | ||
| Gastric Balloons | ||
| Gastric Emptying | ||
| Other Devices | ||
| By End User, Value | Hospitals & Specialty Clinics | |
| Bariatric Surgery Centers | ||
| Ambulatory Surgical Centers | ||
| Others | ||
| By Patient Age Group, Value | Adolescents (12–17) | |
| Adults (18–64) | ||
| Geriatric (≥65) | ||
| By Geography, Value | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the Global Bariatric Surgery Market?
The Global Bariatric Surgery Market size is expected to reach USD 2.80 billion in 2025 and grow at a CAGR of 5.22% to reach USD 3.61 billion by 2030.
What is the current Global Bariatric Surgery Market size?
In 2025, the Global Bariatric Surgery Market size is expected to reach USD 2.80 billion.
Who are the key players in Global Bariatric Surgery Market?
Intuitive Surgical Inc., Olympus Corporation, Medtronic, Johnson and Johnson and Boston Scientific Corporation are the major companies operating in the Global Bariatric Surgery Market.
Which is the fastest growing region in Global Bariatric Surgery Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Global Bariatric Surgery Market?
In 2025, the North America accounts for the largest market share in Global Bariatric Surgery Market.
What years does this Global Bariatric Surgery Market cover, and what was the market size in 2024?
In 2024, the Global Bariatric Surgery Market size was estimated at USD 2.65 billion. The report covers the Global Bariatric Surgery Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Bariatric Surgery Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
